Skip to content

A Clinical Study In the Management Of Chronic Liver Disease.

A Clinical Study To Evaluate The Efficacy Of Kasisadya Vati In The Management Of Chronic Liver Disease W.S.R To Kumbhakamala. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068235
Enrollment
30
Registered
2024-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K74- Fibrosis and cirrhosis of liver

Interventions

None listed

Sponsors

Dr Chepuri Bhargavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Fatty Liver Of Grade 1,2,3. 2. Liver Parenchymal Changes With Or Without Hyperbilirubinemia . 3. Alcoholic Or Non-Alcoholic Liver Disease

Exclusion criteria

Exclusion criteria: 1. Any Viral Infections like Hepatitis-B/A. 2. Hepatorenal Syndrome 3. Hepatopulmonary Syndrome. 4. Hepatic Encephalopathy. 5. Total Bilirubin of Greater than 7mg/dl 6. MELD SCORE Greater than 21 7. Patients who develop Spontaneous Bacterial Peritonitis. 8. Ascitis 9. Diseases Of Gallbladder/ Suffering from Pancreatitis.. 10.Liver Stiffness Of Greater than 30kpa

Design outcomes

Primary

MeasureTime frame
In Normalizing the Abnormal Liver Enzymes.Timepoint: 90 Days

Secondary

MeasureTime frame
Reducing the Stiffness Of LiverTimepoint: 90 Days

Countries

India

Contacts

Public ContactDr A Swaroopa

Dr.BRKR Government Ayurvedic college and hospital.

swaroopa.kusuma95@gmail.com9866275613

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026